S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
Did You See These Trend Reversals? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Is Braze Inc Ready To Rocket Higher? 
Did You See These Trend Reversals? (Ad)pixel
UN body mulls deep sea mining amid demand for minerals
Canada approves largest telecom deal in country's history
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Medicare, Social Security could fall short over next decade
Intensity and insults rise as lawmakers debate debt ceiling
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
Did You See These Trend Reversals? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Is Braze Inc Ready To Rocket Higher? 
Did You See These Trend Reversals? (Ad)pixel
UN body mulls deep sea mining amid demand for minerals
Canada approves largest telecom deal in country's history
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Medicare, Social Security could fall short over next decade
Intensity and insults rise as lawmakers debate debt ceiling
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
Did You See These Trend Reversals? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Is Braze Inc Ready To Rocket Higher? 
Did You See These Trend Reversals? (Ad)pixel
UN body mulls deep sea mining amid demand for minerals
Canada approves largest telecom deal in country's history
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Medicare, Social Security could fall short over next decade
Intensity and insults rise as lawmakers debate debt ceiling
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
Did You See These Trend Reversals? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Is Braze Inc Ready To Rocket Higher? 
Did You See These Trend Reversals? (Ad)pixel
UN body mulls deep sea mining amid demand for minerals
Canada approves largest telecom deal in country's history
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Medicare, Social Security could fall short over next decade
Intensity and insults rise as lawmakers debate debt ceiling
NASDAQ:STAA

STAAR Surgical - STAA Stock Forecast, Price & News

$63.95
+1.54 (+2.47%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$62.74
▼
$64.11
50-Day Range
$55.39
▼
$79.34
52-Week Range
$46.35
▼
$112.27
Volume
413,306 shs
Average Volume
681,880 shs
Market Capitalization
$3.08 billion
P/E Ratio
81.99
Dividend Yield
N/A
Price Target
$82.20

STAAR Surgical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
28.5% Upside
$82.20 Price Target
Short Interest
Bearish
10.55% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.73
Upright™ Environmental Score
News Sentiment
0.44mentions of STAAR Surgical in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$51,001 Sold Last Quarter
Proj. Earnings Growth
104.48%
From $0.67 to $1.37 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.77 out of 5 stars

Medical Sector

28th out of 1,004 stocks

Ophthalmic Goods Industry

1st out of 7 stocks

See Top Rated MarketRank™ Stocks Here

STAA stock logo

About STAAR Surgical (NASDAQ:STAA) Stock

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAA Stock News Headlines

March 31, 2023 | americanbankingnews.com
STAAR Surgical (NASDAQ:STAA) Receives $83.89 Average Price Target from Analysts
March 30, 2023 | marketwatch.com
Ophthalmic Devices Market With New Statistical Report 2029
April 1, 2023 | Legacy Research (Affiliate) (Ad)
Bear market expert makes new prediction
Nobody believed Larry Benedict's prediction in February 2020. The DOW plunged 3.5%, and he told CNBC, "It seems like there's much more to come." Within a month, the market plummeted 34%. Then, nobody believed Larry at the start of last year, either. He predicted that "all the indexes will be negative for the year," with the Nasdaq leading the way. Once again, he was spot-on.
March 30, 2023 | marketwatch.com
Surgical Ophthalmology Market Share and Forecast till 2031
March 29, 2023 | finance.yahoo.com
Staar Surgical (STAA) Stock Sinks As Market Gains: What You Should Know
March 29, 2023 | markets.businessinsider.com
STAAR Surgical Appoints Warren Foust As COO
March 29, 2023 | seekingalpha.com
STAAR Surgical hires Warren Foust as COO
March 28, 2023 | marketwatch.com
Ophthalmic Devices Market Outlook and Forecast till 2030
April 1, 2023 | Legacy Research (Affiliate) (Ad)
Bear market expert makes new prediction
Nobody believed Larry Benedict's prediction in February 2020. The DOW plunged 3.5%, and he told CNBC, "It seems like there's much more to come." Within a month, the market plummeted 34%. Then, nobody believed Larry at the start of last year, either. He predicted that "all the indexes will be negative for the year," with the Nasdaq leading the way. Once again, he was spot-on.
March 24, 2023 | marketwatch.com
Ophthalmic Equipment Market Top Players By 2031
March 24, 2023 | americanbankingnews.com
STAAR Surgical (NASDAQ:STAA) Stock Price Down 3.2%
March 24, 2023 | marketwatch.com
Cataract Surgery Devices Market Outlook By 2031
March 23, 2023 | marketwatch.com
Intraocular Lens (IOL) Material Market Size, Trends and Forecast 2028
March 14, 2023 | msn.com
STAAR Surgical gains after reaffirming sales forecast
March 14, 2023 | marketwatch.com
Monofocal IOLs Market Application, Product, Sales and Forecast 2023-2028
March 13, 2023 | finance.yahoo.com
Implied Volatility Surging for STAAR Surgical (STAA) Stock Options
March 10, 2023 | marketwatch.com
Ophthalmology Cataract Surgery Devices Market Application, Product, Sales and Forecast 2023-2028
March 9, 2023 | finance.yahoo.com
Calculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)
March 8, 2023 | marketwatch.com
Ophthalmic Surgical Instruments Market Application, Product, Sales and Forecast 2023-2028
March 1, 2023 | marketwatch.com
Ophthalmology Surgical Devices Market Industry Analysis, Estimates Size and Projections by 2029
February 27, 2023 | marketwatch.com
Ophthalmic Surgical Devices Market 2023 | Size, Growth Rate, Key Players Share, And Industry Trends Analysis with Global Forecast 2023-2028
February 24, 2023 | seekingalpha.com
STAAR Surgical Shines In Today's Uncertainties Due To Growing U.S. Revenue
February 24, 2023 | marketwatch.com
Ophthalmology Surgical Devices Market 2023 : Incredible Possibilities, Growth Analysis and Forecast To 2028
February 23, 2023 | finance.yahoo.com
STAAR Surgical Full Year 2022 Earnings: EPS: US$0.81 (vs US$0.52 in FY 2021)
February 23, 2023 | markets.businessinsider.com
Mizuho Securities Keeps Their Buy Rating on Staar Surgical (STAA)
February 22, 2023 | benzinga.com
STAAR Surgical shares are trading lower after the company reported mixed Q4 financial results.
February 22, 2023 | markets.businessinsider.com
Stephens Keeps Their Buy Rating on Staar Surgical (STAA)
See More Headlines
Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAA Company Calendar

Last Earnings
11/03/2021
Today
3/31/2023
Next Earnings (Estimated)
5/03/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:STAA
CUSIP
85231230
CIK
718937
Web
www.staar.com
Phone
(626) 303-7902
Fax
626-303-2962
Employees
692
Year Founded
1982

Price Target and Rating

Average Stock Price Forecast
$82.20
High Stock Price Forecast
$125.00
Low Stock Price Forecast
$60.00
Forecasted Upside/Downside
+28.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$0.78
Trailing P/E Ratio
81.99
Forward P/E Ratio
95.45
P/E Growth
N/A
Net Income
$38.76 million
Net Margins
13.63%
Pretax Margin
16.02%
Return on Equity
12.91%
Return on Assets
10.32%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.03
Quick Ratio
5.56

Sales & Book Value

Annual Sales
$284.39 million
Price / Sales
10.85
Cash Flow
$0.92 per share
Price / Cash Flow
69.26
Book Value
$6.89 per share
Price / Book
9.28

Miscellaneous

Outstanding Shares
48,240,000
Free Float
46,982,000
Market Cap
$3.08 billion
Optionable
Optionable
Beta
1.23

Social Links


Key Executives

  • Thomas G. Frinzi
    Chairman, President & Chief Executive Officer
  • Patrick F. WilliamsPatrick F. Williams
    Chief Financial Officer & Vice President
  • Keith HollidayKeith Holliday
    Chief Technology Officer
  • Scott D. Barnes
    Chief Medical Officer
  • Samuel J. GestenSamuel J. Gesten
    Secretary & Chief Legal Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













STAA Stock - Frequently Asked Questions

Should I buy or sell STAAR Surgical stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" STAA shares.
View STAA analyst ratings or view top-rated stocks.

What is STAAR Surgical's stock price forecast for 2023?

10 equities research analysts have issued 1 year price objectives for STAAR Surgical's stock. Their STAA share price forecasts range from $60.00 to $125.00. On average, they anticipate the company's share price to reach $82.20 in the next year. This suggests a possible upside of 28.5% from the stock's current price.
View analysts price targets for STAA or view top-rated stocks among Wall Street analysts.

How have STAA shares performed in 2023?

STAAR Surgical's stock was trading at $48.54 at the beginning of the year. Since then, STAA shares have increased by 31.7% and is now trading at $63.95.
View the best growth stocks for 2023 here.

When is STAAR Surgical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our STAA earnings forecast.

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) announced its quarterly earnings data on Wednesday, November, 3rd. The medical instruments supplier reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.01. The medical instruments supplier had revenue of $58.35 million for the quarter, compared to analysts' expectations of $57.70 million. STAAR Surgical had a trailing twelve-month return on equity of 12.91% and a net margin of 13.63%. During the same quarter in the prior year, the firm posted $0.14 EPS.

What ETFs hold STAAR Surgical's stock?

ETFs with the largest weight of STAAR Surgical (NASDAQ:STAA) stock in their portfolio include Janus Henderson Small Cap Growth Alpha ETF (JSML), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Healthcare Technology and Innovation ETF (HTEC), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), Pacer US Export Leaders ETF (PEXL), Janus Henderson US Sustainable Equity ETF (SSPX), Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC) and AI Powered Equity ETF (AIEQ).

What guidance has STAAR Surgical issued on next quarter's earnings?

STAAR Surgical issued an update on its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $340.00 million-$340.00 million, compared to the consensus revenue estimate of $343.34 million.

What is Caren Mason's approval rating as STAAR Surgical's CEO?

6 employees have rated STAAR Surgical Chief Executive Officer Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among the company's employees.

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by many different institutional and retail investors. Top institutional investors include Baillie Gifford & Co. (10.86%), Geneva Capital Management LLC (1.95%), E Fund Management Co. Ltd. (1.87%), Geode Capital Management LLC (1.87%), Principal Financial Group Inc. (1.42%) and Morgan Stanley (1.10%). Insiders that own company stock include Broadwood Partners, LP, Caren L Mason, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams and Samuel J Gesten.
View institutional ownership trends.

How do I buy shares of STAAR Surgical?

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $63.95.

How much money does STAAR Surgical make?

STAAR Surgical (NASDAQ:STAA) has a market capitalization of $3.08 billion and generates $284.39 million in revenue each year. The medical instruments supplier earns $38.76 million in net income (profit) each year or $0.78 on an earnings per share basis.

How many employees does STAAR Surgical have?

The company employs 692 workers across the globe.

Does STAAR Surgical have any subsidiaries?
The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.
Read More
How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The official website for the company is www.staar.com. The medical instruments supplier can be reached via phone at (626) 303-7902, via email at bmoore@staar.com, or via fax at 626-303-2962.

This page (NASDAQ:STAA) was last updated on 4/1/2023 by MarketBeat.com Staff